Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Juva Life Inc (JUVA.CN)

Juva Life Inc (JUVA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings ACCESS Newswire - Mon Nov 25, 2024

REDWOOD CITY, CA / ACCESSWIRE / November 25, 2024 / Juva Life Inc. (CSE:JUVA)(OTC PINK:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research and development...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)
Juva Life Reports Strong Growth in Q3 2023 Financial Results ACCESS Newswire - Tue Dec 12, 2023

REDWOOD CITY, CA / ACCESSWIRE / December 13, 2023 / Juva Life Inc. (CSE:JUVA)(OTCQB:JUVAF)(FRANKFURT:4VV) ("Juva Life" or the "Company"), Juva Life, Inc, a life science company with both pharmaceutical...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)
Juva Life Highlights Q1 2022 Financials Showing 97% Increase in Revenue Globe Newswire - Tue Jul 19, 2022

Company Reports Its Q1 2022 Results and Provides Comments on Operations...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)
Juva Life Secures $11.8 Million in Financing, Enabling Expansion of Cannabis Operations, Further Clinical Research Globe Newswire - Tue Jun 21, 2022

Cannabis and Life Sciences Company Closes $11.8 Million in Non-Dilutive Debt Financing...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)
Juva Life Granted First-of-Its-Kind License for Retail Cannabis Storefront in Redwood City, California Globe Newswire - Wed Apr 6, 2022

In Highly Competitive Process, Vertically Integrated California Cultivator and Life Science Research Company Approved to Launch Brick-and-Mortar Location...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)
Juva Life Launches First In-House Branded Product: ‘Secret Sauce’ Concentrate – in Response to Market Segment Growth Globe Newswire - Wed Mar 30, 2022

Vertically Integrated California Cultivator and Life Science Research Company Expands Strategically Into New Category...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)
Juva Life Announces Webinar Takeaways, Showcasing Increased Production Output, Operational Milestones and Pharmaceutical Advancements Globe Newswire - Thu Mar 24, 2022

Cannabis and Life Sciences Company Webinar Highlights Milestones, Growth and Future Plans...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)
Juva Life Announces Completion of Stockton, California, Cannabis Cultivation Facility, Doubling Harvest Capacity Globe Newswire - Mon Mar 21, 2022

Cannabis and Life Sciences Company Doubles Capacity of Stockton Cultivation Facility With Completed Construction...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)
Stocks in play: Juva Life Inc Baystreet - Wed Mar 2, 2022

Announced today the launch of the Company’s Journal App, designed to help cannabis users and patients ...

JUVA.CN : 0.0200 (-20.00%)
Juva Life Launches Journal App, Offering Personal Health and Wellness Tracking for Cannabis Patients Globe Newswire - Wed Mar 2, 2022

Life Science Research & Vertically Integrated California Cultivator Offers App to Help Consumers Track Cannabis Effects on Their Health and Wellness...

JUVA.CN : 0.0200 (-20.00%)
JUVAF : 0.0001 (unch)

Barchart Exclusives

After Rigetti Announced a Quantum Computing Delay, How Should You Play RGTI Stock in January 2026? Barchart - 52 minutes ago
Rigetti’s delay of its flagship 108-qubit Cepheus system rattled investor confidence. Is RGTI still worth buying this month? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot